154 related articles for article (PubMed ID: 18665761)
1. Efficacy of low-level laser therapy in Ménière's disease: a pilot study of 10 patients.
Teggi R; Bellini C; Fabiano B; Bussi M
Photomed Laser Surg; 2008 Aug; 26(4):349-53. PubMed ID: 18665761
[TBL] [Abstract][Full Text] [Related]
2. Transtympanic steroids for Ménière's disease.
Herraiz C; Plaza G; Aparicio JM; Gallego I; Marcos S; Ruiz C
Otol Neurotol; 2010 Jan; 31(1):162-7. PubMed ID: 19924013
[TBL] [Abstract][Full Text] [Related]
3. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
[TBL] [Abstract][Full Text] [Related]
4. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
[TBL] [Abstract][Full Text] [Related]
5. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
Ganança MM; Caovilla HH; Ganança FF
Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
[TBL] [Abstract][Full Text] [Related]
6. Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up.
Densert B; Sass K
Acta Otolaryngol; 2001 Jul; 121(5):616-21. PubMed ID: 11583396
[TBL] [Abstract][Full Text] [Related]
7. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
Kluyskens P; Lambert P; D'Hooge D
Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
[TBL] [Abstract][Full Text] [Related]
8. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
Novotný M; Kostrica R
Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
[TBL] [Abstract][Full Text] [Related]
9. Effects of endolymphatic sac drainage with steroids for intractable Meniere's disease: a long-term follow-up and randomized controlled study.
Kitahara T; Kubo T; Okumura S; Kitahara M
Laryngoscope; 2008 May; 118(5):854-61. PubMed ID: 18520184
[TBL] [Abstract][Full Text] [Related]
10. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
11. Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial.
Strupp M; Hupert D; Frenzel C; Wagner J; Hahn A; Jahn K; Zingler VC; Mansmann U; Brandt T
Acta Otolaryngol; 2008 May; 128(5):520-4. PubMed ID: 18421605
[TBL] [Abstract][Full Text] [Related]
12. Posterior fossa vestibular neurotomy as primary surgical treatment of Menière's disease: a re-evaluation.
Pareschi R; Destito D; Falco Raucci A; Righini S; Colombo S
J Laryngol Otol; 2002 Aug; 116(8):593-6. PubMed ID: 12389685
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
[TBL] [Abstract][Full Text] [Related]
14. Antisecretory factor-inducing therapy improves the clinical outcome in patients with Ménière's disease.
Hanner P; Rask-Andersen H; Lange S; Jennische E
Acta Otolaryngol; 2010 Feb; 130(2):223-7. PubMed ID: 19479454
[TBL] [Abstract][Full Text] [Related]
15. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
16. Serum antidiuretic hormone levels in patients with unilateral Meniere's disease.
Lim JS; Lange ME; Megerian CA
Laryngoscope; 2003 Aug; 113(8):1321-6. PubMed ID: 12897553
[TBL] [Abstract][Full Text] [Related]
17. Transmeatal low-level laser therapy for chronic tinnitus with cochlear dysfunction.
Teggi R; Bellini C; Piccioni LO; Palonta F; Bussi M
Audiol Neurootol; 2009; 14(2):115-20. PubMed ID: 18843180
[TBL] [Abstract][Full Text] [Related]
18. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
[TBL] [Abstract][Full Text] [Related]
19. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
Kasemsuwan L; Jariengprasert C; Chaturapatranont S
J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
[TBL] [Abstract][Full Text] [Related]
20. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
